TLCD1 and metabolic dysfunction-associated steatohepatitis: The level of hepatic lipidosis was similar between Tlcd1/2 DKO and controls in the WD NASH mouse model, suggesting that TLCD1/2 can modulate NASH progression independently of hepatic DNL gene transcription and subsequent lipid accumulation.